---
title: "Velocity-dependent friction controls theta–gamma coupling and stability in a two-oscillator model"
id: "biorxiv-13-velocity-dependent-friction-in-a-simple-two-oscillator-system-ii-regions-of"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-13-velocity-dependent-friction-in-a-simple-two-oscillator-system-ii-regions-of"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Velocity-dependent friction controls theta–gamma coupling and stability in a two-oscillator model
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-13-velocity-dependent-friction-in-a-simple-two-oscillator-system-ii-regions-of
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors extended Part I by asking when a gamma oscillator destabilizes under a **velocity-dependent friction** that follows **theta** velocity; Part I had shown such friction produces **phase amplitude coupling** (PAC) with strength set by a dimensionless number, kappa. - The model places negative friction on gamma during part of each theta cycle, but energy gained while theta rises is typically returned when theta falls, so gamma remains bounded under ordinary cycles by Liouville's formula. - Instability arises only when rare, large-amplitude theta cycles produce friction exceeding critical damping, halting gamma oscillation so that the previously returned energy is not recovered. - The transition to typical instability depends on the frequency of these rare events: when such cycles (about one in a hundred) outweigh baseline decay across other cycles, instability appears; this yields a boundary expressed as g* σx = 10, where σx is the typical theta amplitude determined by the fluctuation–dissipation theorem. - The paper reports that this analytic boundary matches a direct Lyapunov scan to within 6% over damping ratios from 0.0005 to 0.0055, and that the distance to the boundary is set by the same kappa that determines PAC strength (stronger PAC means closer proximity to instability). - A mean-square boundary lies much lower in parameter space but is determined by events of negligible probability and therefore not the typical instability threshold. - External stimulation of theta at or below its own frequency raises gamma energy and PAC and can drive very large gamma bursts or divergence; however, stimulation alone did not produce self-sustained gamma activity in the model, and the authors state that a transition to seizure-like persistent activity would require memory mechanisms not present in this simple system. - The authors noted no competing interests and provided supplementary code/data links; the article is a preprint and has not been peer reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=I.uuVAXDVd5YWbelBl6mDBHfrb5otcFg6QqBU8B9iWg-1795202419.951964-1.2.1.1-tGtERplYRxcya5VJsmAMTswTWouy9cJ6zavKgnE3t3KTCeiI5e9AtEmWFEXj0Vs.) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Velocity-dependent friction in a simple two-oscillator system. II. Regions of stability [ View ORCID Profile](http://orcid.org/0009-0001-8335-1855)YuHan Luo, Nayak Sonali Priyadarshini, Murielle Hsu, Greg Worrell, [ View ORCID Profile](http://orcid.org/0000-0002-8343-0406)David Hsu doi: https://doi.org/10.64898/2026.11.18.767758 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. YuHan Luo 1 University of Wisconsin-Madison; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=YuHan%2BLuo%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Luo%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYuHan%2BLuo%2B) * [ORCID record for YuHan Luo](http://orcid.org/0009-0001-8335-1855 "Open in new tab") Nayak Sonali Priyadarshini 2 Department of Chemistry, Boston University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nayak%2BSonali%2BPriyadarshini%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Priyadarshini%20NS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ANayak%2BSonali%2BPriyadarshini%2B) Murielle Hsu 3 Department of Neurology, University of Wisconsin School of Medicine and Public Health; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Murielle%2BHsu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hsu%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMurielle%2BHsu%2B) Greg Worrell 4 Mayo Clinic * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Greg%2BWorrell%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Worrell%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AGreg%2BWorrell%2B) David Hsu 3 Department of Neurology, University of Wisconsin School of Medicine and Public Health; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=David%2BHsu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hsu%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADavid%2BHsu%2B) * [ORCID record for David Hsu](http://orcid.org/0000-0002-8343-0406 "Open in new tab") * For correspondence: hsu@neurology.wisc.edu * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5981319/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5981319/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5981319/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5981319/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5981319/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5981319/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract In Part I, a gamma friction that follows theta velocity produced theta gamma phase amplitude coupling (PAC) whose strength is a closed-form function of one dimensionless number, kappa;. Here we ask when this coupling destabilizes the gamma oscillator. The friction on gamma is negative during part of every theta cycle, yet gamma stays bounded: as long as it keeps oscillating, the energy gained while theta rises is returned while theta falls, and Liouville' sformula fixes the growth over a theta cycle at the baseline decay, whatever the coupling. Instability arises only in rare large theta cycles in which the friction exceeds critical damping, so that gamma stops oscillating and the gain is no longer returned. The typical trajectory becomes unstable when such cycles, about one in a hundred, outweigh the decay in all the others. This gives a boundary g* σx = 10, where σx is the typical theta amplitude set by the fluctuation dissipation theorem; the prediction agrees with a direct Lyapunov scan to within 6% for damping ratios from 0.0005 to 0.0055. The distance to the boundary is set by the same number kappa that sets the PAC strength, so that stronger PAC means closer proximity to instability. The mean-square boundary lies far lower but is set by events of negligible probability. Stimulating theta at or below its own frequency raises gamma energy and PAC and can drive giant gamma bursts or divergence, but no self-sustained activity, suggesting that a transition to seizure requires memory. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.18.767047v1 "The creatine transporter SLC6A8 is an immune pressure-exposed metabolic vulnerability in acute myeloid leukemia") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.18.767758.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.18.767758v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/20/2026.11.18.767758.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Velocity-dependent friction in a simple two-oscillator system. II. Regions of stability YuHan Luo, Nayak Sonali Priyadarshini, Murielle Hsu, Greg Worrell, David Hsu bioRxiv 2026.11.18.767758; doi: https://doi.org/10.64898/2026.11.18.767758 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767758v1%26text%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520II.%2520Regions%2520of%2520stability "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767758v1%26t%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520II.%2520Regions%2520of%2520stability "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767758v1%26title%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520II.%2520Regions%2520of%2520stability%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767758v1%26title%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520II.%2520Regions%2520of%2520stability "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.18.767758) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46166) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20382) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27662) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14300) * [Ecology](https://www.biorxiv.org/collection/ecology) (21652) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (26061) * [Genetics](https://www.biorxiv.org/collection/ge
## Related Clinical Research

- [Velocity-dependent friction model explains theta–gamma phase–amplitude coupling](https://medichelpline.com/clinical-feed/biorxiv-12-velocity-dependent-friction-in-a-simple-two-oscillator-system-i-phase-amplitude.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [Psychotropic drug prescribing trends in Dutch nursing home residents with dementia, 2016–2023](https://medichelpline.com/clinical-feed/plos-one-17-trends-in-psychotropic-drug-use-in-nursing-home-residents-with-dementia-and.md)
- [fMRI-based ARC tool differentiates SuperAgers from Alzheimer’s with strong AUC](https://medichelpline.com/clinical-feed/medical-news-today-2-new-brain-imaging-tool-distinguishes-between-alzheimer-s-disease-and-superagers.md)
- [SLC6A8 creatine transporter identified as an immune pressure–exposed metabolic vulnerability in ac](https://medichelpline.com/clinical-feed/biorxiv-0-the-creatine-transporter-slc6a8-is-an-immune-pressure-exposed-metabolic.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.